Principales conclusions et analyse des parts de marché du traitement au glucagon d'ici 2025-2031
Glucagon Therapy Market Report Analysis
Glucagon Therapy Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Xeris Pharmaceuticals Inc.
- Svar Life Science AB
- Novo Nordisk A/S
- Lilly
- Taj Pharmaceuticals Ltd
- Fresenius SE and Co. KGaA
- Torrent Pharmaceuticals Ltd
- Ferozsons Laboratories Limited
- Zealand Pharma A/S
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type de produit
- Glucagon injectable
- Glucagon nasal
By Type d'application
- usage général
- kit d'urgence
- diagnostic et motilité
- choc cardiogénique
- autres
By Utilisateur final
- hôpitaux
- cliniques spécialisées
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For